info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

August, 2019, Volume 20, 3, pp 15169-15170

Mini Review

Mini Review

The Fetal Patient, Beyond Prenatal Diagnosis

Elia Lara Lona1*, Ma de la Luz Bermúdez Rojas2 and Daniel Diaz Martínez2

Author Affiliations

1Department of Medicine and Nutrition, Mexico

2Ministry of Health, State Center for Timely Screening, Mexico

Received:August 07, 2019 | Published: August 14 2019

Corresponding author:Elia Lara Lona, Department of Medicine and Nutrition, University of Guanajuato, Mexico

DOI: 10.26717/BJSTR.2019.20.003477

Mini Review

Since the three technological innovations that make up the device for prenatal diagnosis (amniocentesis, genetic identification and ultrasound) [1,2], were developed and consolidated, the technology for therapeutic intervention has also developed exponentially, with consequences for the fetus and the pregnant woman who have undergone of multiple approaches to public health policy with social accounts of impact on maternity, kinship and general society [3-5].

The efforts of governments to make timely diagnoses that prevent premature death or disability are variable depending on priority and financial resources, but the commitment should not remain there, but to ensure care for the pathologies identified. Although it has been shown that strategies for the prevention and timely identification of pathologies in the perinatal period should be carried out from the first weeks of gestation and even from the preconception period, the data show that diagnoses have generally been made from the 2nd and 3rd trimester of pregnancy.

There are several causes that favor that the pregnant woman’s first contact with the health system be delayed, basically due to the criteria of access to health services, organizational barriers in establishments, quality of care and processes socio-cultural and ideological issues

In the state of Guanajuato in Mexico, located in the center of the country, a comprehensive strategy for the timely identification of pathologies in the fetus and mother has been implemented following the model proposed by [6] of the turn the pyramid of prevention and guaranteeing pharmacological treatment (progesterone), nonpharmacological (psychology, genetic counseling, nutrition) and surgical (fetal surgery or cerclage) as appropriate. The strategy includes the identification of risks for both the fetus and the mother in 4 main lines: birth defects, probability of presenting intrauterine growth retardation, pre-eclampsia and prematurity.

One of the most important aspects to highlight is the scheme of financing and assurance of care for the mother, the fetus and the follow-up until two years after birth, which has been possible with the model of the Social Protection System in Health, the resource of the state itself and with the support of civil society. Five years after its implementation, there have been amazing results with the attention of more than 26 thousand pregnant women..

References

Mini Review

The Fetal Patient, Beyond Prenatal Diagnosis

Elia Lara Lona1*, Ma de la Luz Bermúdez Rojas2 and Daniel Diaz Martínez2

Author Affiliations

1Department of Medicine and Nutrition, Mexico

2Ministry of Health, State Center for Timely Screening, Mexico

Received:August 07, 2019 | Published: August 14, 2019

Corresponding author:Elia Lara Lona, Department of Medicine and Nutrition, University of Guanajuato, Mexico

DOI: 10.26717/BJSTR.2019.20.003477

Abstract

Since the three technological innovations that make up the device for prenatal diagnosis (amniocentesis, genetic identification and ultrasound) [1,2], were developed and consolidated, the technology for therapeutic intervention has also developed exponentially, with consequences for the fetus and the pregnant woman who have undergone of multiple approaches to public health policy with social accounts of impact on maternity, kinship and general society